Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Debnath J, Baehrecke EH, Kroemer G. Does autophagy contribute to cell death? Autophagy. 2005;1:66–74.
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell. 2019;176:11–42.
   PubMed Web of Science ®Google Scholar
• Lock R, Kenific CM, Leidal AM, et al. Autophagy-dependent production of secreted factors facilitates oncogenic RAS-driven invasion. Cancer Discov. 2014;4:466–479.
   PubMed Web of Science ®Google Scholar
• Qiang L, Zhao B, Ming M, et al. Regulation of cell proliferation and migration by p62 through stabilization of Twist1. Proc Natl Acad Sci USA. 2014;111:9241–9246.
   PubMed Web of Science ®Google Scholar
• Akalay I, Janji B, Hasmim M, et al. Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis. Cancer Res. 2013;73:2418–2427.
   PubMed Web of Science ®Google Scholar
• Lazova R, Camp RL, Klump V, et al. Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clin Cancer Res. 2012;18:370–379.
   PubMed Web of Science ®Google Scholar
• Lazova R, Klump V, Pawelek J. Autophagy in cutaneous malignant melanoma. J Cutan Pathol. 2010;37:256–268.
   PubMed Web of Science ®Google Scholar
• Galavotti S, Bartesaghi S, Faccenda D, et al. The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. Oncogene. 2013;32:699–712.
   PubMed Web of Science ®Google Scholar
• Garneau H, Paquin MC, Carrier JC, et al. E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells. J Cell Physiol. 2009;221:350–358.
   PubMed Web of Science ®Google Scholar
• Moberg K, Starz MA, Lees JA. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol. 1996;16:1436–1449.
   PubMed Web of Science ®Google Scholar
• Lee EY, Cam H, Ziebold U, et al. E2F4 loss suppresses tumorigenesis in Rb mutant mice. Cancer Cell. 2002;2:463–472.
   PubMed Web of Science ®Google Scholar
• Rakha EA, Pinder SE, Paish EC, et al. Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis. J Pathol. 2004;203:754–761.
   PubMed Web of Science ®Google Scholar
• Cheng C, Varn FS, Marsit CJ. E2F4 program is predictive of progression and intravesical immunotherapy efficacy in bladder cancer. Mol Cancer Res. 2015;13:1316–1324.
   PubMed Web of Science ®Google Scholar
• Lachmann A, Xu H, Krishnan J, et al. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics. 2010;26:2438–2444.
   PubMed Web of Science ®Google Scholar
• O’Leary B, Finn RS, Turner NC. Treating cancer with selective CDK4/6 inhibitors. Nat Rev Clin Oncol. 2016;13:417–430.
   PubMed Web of Science ®Google Scholar
• Gilbert LA, Horlbeck MA, Adamson B, et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell. 2014;159:647–661.
   PubMed Web of Science ®Google Scholar
• Cherian MG, Jayasurya A, Bay BH. Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res. 2003;533:201–209.
   PubMed Web of Science ®Google Scholar
• Schellens JP, Vreeling-Sindelárová H, Plomp PJ, et al. Hepatic autophagy and intracellular ATP. A morphometric study. Exp Cell Res. 1988;177:103–108.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 2021;17:1–382.
   PubMed Web of Science ®Google Scholar
• Hateboer G, Kerkhoven RM, Shvarts A, et al. Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev. 1996;10:2960–2970.
   PubMed Web of Science ®Google Scholar
• Wang CL, Wang JY, Liu ZY, et al. Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma. Carcinogenesis. 2014;35:1500–1509.
   PubMed Web of Science ®Google Scholar
• Shan J, Zhao W, Gu W. Suppression of cancer cell growth by promoting cyclin D1 degradation. Mol Cell. 2009;36:469–476.
   PubMed Web of Science ®Google Scholar
• Stevenson LF, Sparks A, Allende-Vega N, et al. The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2. EMBO J. 2007;26:976–986.
   PubMed Web of Science ®Google Scholar
• Zhou H, Yuan M, Yu Q, et al. Autophagy regulation and its role in gastric cancer and colorectal cancer. Cancer Biomark. 2016;17:1–10.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147:728–741.
   PubMed Web of Science ®Google Scholar
• Cuervo AM. Autophagy: in sickness and in health. Trends Cell Biol. 2004;14:70–77.
   PubMed Web of Science ®Google Scholar
• Funderburk SF, Wang QJ, Yue Z. The Beclin 1-VPS34 complex-at the crossroads of autophagy and beyond. Trends Cell Biol. 2010;20:355–362.
   PubMed Web of Science ®Google Scholar
• Liang XH, Jackson S, Seaman M, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402:672–676.
   PubMed Web of Science ®Google Scholar
• Qu X, Yu J, Bhagat G, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest. 2003;112:1809–1820.
   PubMed Web of Science ®Google Scholar
• Takamura A, Komatsu M, Hara T, et al. Autophagy-deficient mice develop multiple liver tumors. Genes Dev. 2011;25:795–800.
   PubMed Web of Science ®Google Scholar
• Jo YK, Kim SC, Park IJ, et al. Increased expression of ATG10 in colorectal cancer is associated with lymphovascular invasion and lymph node metastasis. PLoS One. 2012;7:e52705.
   PubMed Web of Science ®Google Scholar
• Deen NS, Huang SJ, Gong L, et al. The impact of autophagic processes on the intracellular fate of Helicobacter pylori: more tricks from an enigmatic pathogen? Autophagy. 2013;9:639–652.
   PubMed Web of Science ®Google Scholar
• Qu B, Yao L, Ma HL, et al. Prognostic significance of autophagy-related proteins expression in resected human gastric adenocarcinoma. J Huazhong Univ Sci Technolog Med Sci. 2017;37:37–43.
   PubMedGoogle Scholar
• Ge J, Chen Z, Huang J, et al. Upregulation of autophagy-related gene-5 (ATG-5) is associated with chemoresistance in human gastric cancer. PLoS One. 2014;9:e110293.
   PubMed Web of Science ®Google Scholar
• Velikkakath AKG, Nishimura T, Oita E, et al. Mammalian Atg2 proteins are essential for autophagosome formation and important for regulation of size and distribution of lipid droplets. Mol Biol Cell. 2012;23:896–909.
   PubMed Web of Science ®Google Scholar
• Kim YH, Baek SH, Kim EK, et al. Uncoordinated 51-like kinase 2 signaling pathway regulates epithelial-mesenchymal transition in A549 lung cancer cells. FEBS Lett. 2016;590:1365–1374.
   PubMed Web of Science ®Google Scholar
• Di Virgilio F, Adinolfi E. Extracellular purines, purinergic receptors and tumor growth. Oncogene. 2017;36:293–303.
   PubMed Web of Science ®Google Scholar
• Follo C, Cheng Y, Richards WG, et al. Autophagy facilitates the release of immunogenic signals following chemotherapy in 3D models of mesothelioma. Mol Carcinog. 2019;58:1754–1769.
   PubMed Web of Science ®Google Scholar
• Stagg J, Smyth MJ. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene. 2010;29:5346–5358.
   PubMed Web of Science ®Google Scholar
• Ledur PF, Villodre ES, Paulus R, et al. Extracellular ATP reduces tumor sphere growth and cancer stem cell population in glioblastoma cells. Purinergic Signal. 2012;8:39–48.
   PubMed Web of Science ®Google Scholar
• Martin S, Dudek-Peric AM, Garg AD, et al. An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAF(V600E) inhibitor-resistant metastatic melanoma cells. Autophagy. 2017;13:1512–1527.
   PubMed Web of Science ®Google Scholar
• Li WH, Qiu Y, Zhang HQ, et al. P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells. Br J Cancer. 2013;109:1666–1675.
   PubMed Web of Science ®Google Scholar
• Biswas D, Qureshi OS, Lee WY, et al. ATP-induced autophagy is associated with rapid killing of intracellular mycobacteria within human monocytes/macrophages. BMC Immunol. 2008;9:35.
   PubMed Web of Science ®Google Scholar
• Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol Rev. 1993;73:79–118.
   PubMed Web of Science ®Google Scholar
• Andreini C, Banci L, Bertini I, et al. Counting the zinc-proteins encoded in the human genome. J Proteome Res. 2006;5:196–201.
   PubMed Web of Science ®Google Scholar
• Krizkova S, Ryvolova M, Hrabeta J, et al. Metallothioneins and zinc in cancer diagnosis and therapy. Drug Metab Rev. 2012;44:287–301.
   PubMed Web of Science ®Google Scholar
• Margalit O, Simon AJ, Yakubov E, et al. Zinc supplementation augments in vivo antitumor effect of chemotherapy by restoring p53 function. Int J Cancer. 2012;131:E562–568.
   PubMed Web of Science ®Google Scholar
• Pedersen M, Larsen A, Stoltenberg M, et al. The role of metallothionein in oncogenesis and cancer prognosis. Prog Histochem Cytochem. 2009;44:29–64.
   PubMed Web of Science ®Google Scholar
• Cho YH, Lee SH, Lee SJ, et al. A role of metallothionein-3 in radiation-induced autophagy in glioma cells. Sci Rep. 2020;10:2015.
   PubMed Web of Science ®Google Scholar
• Vinkenborg JL, Nicolson TJ, Bellomo EA, et al. Genetically encoded FRET sensors to monitor intracellular Zn2+ homeostasis. Nat Methods. 2009;6:737–740.
   PubMed Web of Science ®Google Scholar
• Shi Y, Solomon LR, Pereda-Lopez A, et al. Ubiquitin-specific cysteine protease 2a (USP2a) regulates the stability of Aurora-A. J Biol Chem. 2011;286:38960–38968.
   PubMed Web of Science ®Google Scholar
• Mahul-Mellier AL, Pazarentzos E, Datler C, et al. De-ubiquitinating protease USP2a targets RIP1 and TRAF2 to mediate cell death by TNF. Cell Death Differ. 2012;19:891–899.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zanata SM, Kim J, et al. The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation. Oncogene. 2013;32:1660–1669.
   PubMed Web of Science ®Google Scholar
• Kim J, Kim WJ, Liu Z, et al. The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer. Cell Cycle. 2012;11:1123–1130.
   PubMed Web of Science ®Google Scholar
• Priolo C, Tang D, Brahamandan M, et al. The isopeptidase USP2a protects human prostate cancer from apoptosis. Cancer Res. 2006;66:8625–8632.
   PubMed Web of Science ®Google Scholar
• Qu Q, Mao Y, Xiao G, et al. USP2 promotes cell migration and invasion in triple negative breast cancer cell lines. Tumor Biol. 2015;36:5415–5423.
   PubMedGoogle Scholar
• Savarino A, Lucia MB, Giordano F, et al. Risks and benefits of chloroquine use in anticancer strategies. Lancet Oncol. 2006;7:792–793.
   PubMed Web of Science ®Google Scholar
• Thorburn A. Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis. 2008;13:1–9.
   PubMed Web of Science ®Google Scholar
• Moller M, Herzer K, Wenger T, et al. The alkaloid emetine as a promising agent for the induction and enhancement of drug-induced apoptosis in leukemia cells. Oncol Rep. 2007;18:737–744.
   PubMed Web of Science ®Google Scholar
• Kim JH, Cho EB, Lee J, et al. Emetine inhibits migration and invasion of human non-small-cell lung cancer cells via regulation of ERK and p38 signaling pathways. Chem Biol Interact. 2015;242:25–33.
   PubMed Web of Science ®Google Scholar
• Sun Q, Yogosawa S, Iizumi Y, et al. The alkaloid emetine sensitizes ovarian carcinoma cells to cisplatin through downregulation of bcl-xL. Int J Oncol. 2015;46:389–394.
   PubMed Web of Science ®Google Scholar
• Jiang G, Zheng L, Pu J, et al. Small RNAs targeting transcription start site induce heparanase silencing through interference with transcription initiation in human cancer cells. PLoS One. 2012;7:e31379.
   PubMed Web of Science ®Google Scholar
• Fang E, Wang X, Wang J, et al. Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression. Theranostics. 2020;10:1555–1571.
   PubMed Web of Science ®Google Scholar
• Li H, Yang F, Hu A, et al. Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression. EMBO Mol Med. 2019;11:e10835.
   PubMed Web of Science ®Google Scholar
• Fang E, Wang X, Yang F, et al. Therapeutic targeting of MZF1-AS1/PARP1/E2F1 axis inhibits proline synthesis and neuroblastoma progression. Adv Sci. 2019;6:1900581.
   Web of Science ®Google Scholar
• Chen Y, Yang F, Fang E, et al. Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes. Cell Death Differ. 2019;26:1346–1364.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Singh R, Aschner M. Methods for the detection of autophagy in mammalian cells. Curr Protoc Toxicol. 2016;69:20.12.21–20.12.26.
   PubMedGoogle Scholar
• Li D, Mei H, Pu J, et al. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2. Mol Cancer. 2015;14:47.
   PubMed Web of Science ®Google Scholar
• Qu H, Zheng L, Pu J, et al. miRNA-558 promotes tumorigenesis and aggressiveness of neuroblastoma cells through activating the transcription of heparanase. Hum Mol Genet. 2015;24:2539–2551.
   PubMed Web of Science ®Google Scholar
• Zhao X, Li D, Pu J, et al. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression. Oncogene. 2016;35:3565–3576.
   PubMed Web of Science ®Google Scholar
• Li D, Song H, Mei H, et al. Armadillo repeat containing 12 promotes neuroblastoma progression through interaction with retinoblastoma binding protein 4. Nat Commun. 2018;9:2829.
   PubMed Web of Science ®Google Scholar
• Zheng L, Qi T, Yang D, et al. microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1. PLoS One. 2013;8:e55719.
   PubMed Web of Science ®Google Scholar
• Seidlitz T, Merker SR, Rothe A, et al. Human gastric cancer modelling using organoids. Gut. 2019;68:207–217.
   PubMed Web of Science ®Google Scholar
• Jiao W, Chen Y, Song H, et al. HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis. Oncogene. 2018;37:2728–2745.
   PubMed Web of Science ®Google Scholar